Loading ...

Stock Quote pxs

pxs Stock Price Today

pxs Price History

pxs Stock Price History

pxs History

Last Price pxs

Close Price pxs

Day Change pxs

After Hours Quote pxs

Open Price pxs

Day Range pxs

Year Range pxs

Projected Yield pxs

Market Cap pxs

Stock Volume pxs

Average Volume pxs

Forward Price pxs

PE for pxs

PB for pxs

PS for pxs

PCF for pxs

price earnings ratio pxs

price to book ratio pxs

price to sales ratio pxs

price to cash flow ratio pxs

Stock Quote Pharmaxis Ltd

Pharmaxis Ltd Stock Price today

Pharmaxis Ltd Price history

Pharmaxis Ltd Stock Price history

Pharmaxis Ltd history

Last Price Pharmaxis Ltd

Close Price Pharmaxis Ltd

Day Change Pharmaxis Ltd

After Hours Quote for Pharmaxis Ltd

Open Price Pharmaxis Ltd

Day Range Pharmaxis Ltd

Year Range Pharmaxis Ltd

Projected Yield Pharmaxis Ltd

Market Cap Pharmaxis Ltd

Stock Volume Pharmaxis Ltd

Average Volume Pharmaxis Ltd

Forward Price Pharmaxis Ltd

pe Pharmaxis Ltd

pb Pharmaxis Ltd

ps Pharmaxis Ltd

pcf Pharmaxis Ltd

price earnings ratio Pharmaxis Ltd

price to book ratio Pharmaxis Ltd

price to sales ratio Pharmaxis Ltd

price to cash flow ratio Pharmaxis Ltd

What Does This Company Do?
Pharmaxis Ltd is engaged in the research, development and commercialization of human healthcare products for the treatment and management of respiratory diseases. Its commercial product includes Aridol.
Sector
Healthcare
Industry
Drug Manufacturers - Major
Stock Type
Employees
93
Stock Style
Small Core

Key Stats  PXS More...

Key Stats PXS

S&P 500 index data: S&P 500 Copyright ©

All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .

News  pxs - Pharmaxis Ltd More...

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days

Analysis  pxs - Pharmaxis Ltd More...

Free Issue - Morningstar's Dividend Newsletter
More...

An investment is only as good as the cash it returns directly to your pockets. That's why Morningstar DividendInvestor's buy and sell recommendations are driven entirely by dividends. Our total-return strategy gives you carefully selected, picks that combine current income and income growth to generate large, reliable and growing cash returns. Click to try!

More reports pxs - Pharmaxis LtdMore...

Click above to view more mutual fund data and stats for pxs - Pharmaxis Ltd.

  • Performance
  • Asset Allocation
  • Dividend and Capital Gains Distribution
  • News, Alerts and Opinions
  • Video reports
  • Management
  • Filings

Ownership   PXS More ...

Ownership PXS

DFA International Small Company I
DFA Asia Pacific Small Company I
DFA VA International Small
Wells Fargo Advantage DJ Target 2030 A
Wells Fargo Advantage DJ Target 2040 A

Wall St. Recommendations  pxs - Pharmaxis Ltd More...

Wall Street Analyst Recommendation PXS

Stock Price Quote: pxs Pharmaxis Ltd - XASX - Morningstar
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry

Previous: paa - Pharmaust Ltd  |  Next: pxsly - Pharmaxis Ltd ADR